Generic variations of a groundbreaking injectable HIV-prevention drug needs to be out there for $40 a 12 months in additional than 100 nations from 2027, in response to Unitaid and the Gates Basis. The 2 organisations have entered into separate agreements with Indian pharmaceutical corporations to provide cheaper generic variations of lenacapavir — a twice-yearly injection proven to cut back the chance of HIV transmission by greater than 99.9 % — for low- and middle-income nations. Particulars by Unitaid government directorn Philippe Duneton.
Source link
A chance to end the global HIV epidemic: low-cost preventative drug to roll out on 2027
Recommended For You
